Selected article for: "acute respiratory syndrome and long elevated"
Author: Kow, Chia Siang; Hasan, Syed Shahzad
Title: The potential benefit of telmisartan to protect overweight COPD patients from the acquisition of COVID‐19
  • Cord-id: cvce4gtl
  • Document date: 2020_7_21
    • ID: cvce4gtl
    Snippet: Individuals with chronic obstructive pulmonary disease (COPD) have long been identified to have an elevated serum level of angiotensin‐converting enzyme 2 (ACE2), the cellular entry receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The newest discoveries by Higham et al. (1) were the increased ACE2 expression in the bronchial epithelium of overweight COPD patients compared to their non‐overweight counterparts.
    Document: Individuals with chronic obstructive pulmonary disease (COPD) have long been identified to have an elevated serum level of angiotensin‐converting enzyme 2 (ACE2), the cellular entry receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The newest discoveries by Higham et al. (1) were the increased ACE2 expression in the bronchial epithelium of overweight COPD patients compared to their non‐overweight counterparts.

    Search related documents:
    Co phrase search for related documents
    • activity expression and long term administration: 1
    • activity expression and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adipose tissue and long term administration: 1
    • adipose tissue and lung injury: 1, 2, 3, 4, 5, 6, 7